DNA methylation biomarkers in cancer: progress towards clinical implementation.
about
A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinomaRevealing the Complexity of Breast Cancer by Next Generation SequencingChallenges of deciphering gastric cancer heterogeneityDNA methylation biomarkers: cancer and beyondArtificial light at night: melatonin as a mediator between the environment and epigenomeIdentification and characterization of locus-specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis.A novel method for identification and quantification of consistently differentially methylated regionsEpigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsPreterm birth and its long-term effects: methylation to mechanisms.ZNF695 methylation predicts a response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer.Improved PCR performance using template DNA from formalin-fixed and paraffin-embedded tissues by overcoming PCR inhibition.DNA methylation ratio variability may impede clinical application of cancer diagnostic markers.Measuring whole genome methylation via oxygen channelling chemistry.p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expressionEnhanced reduced representation bisulfite sequencing for assessment of DNA methylation at base pair resolution.Aberrant methylation patterns in cancer: a clinical view.MethPat: a tool for the analysis and visualisation of complex methylation patterns obtained by massively parallel sequencing.Methylation profiling of normal individuals reveals mosaic promoter methylation of cancer-associated genes.SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers.A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantationIdentification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling.Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development.Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative studyImmunomediated Pan-cancer Regulation Networks are Dominant Fingerprints After Treatment of Cell Lines with Demethylation.DNA methylation in ductal carcinoma in situ of the breast.SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas.An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder CancerGenome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.Refining Pharmacologic Research to Prevent and Treat Spontaneous Preterm Birth.Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer.DNA methylation and cancer diagnosis.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.MGMT testing--the challenges for biomarker-based glioma treatment.Strategies for validation and testing of DNA methylation biomarkers.The potential of DNA modifications as biomarkers and therapeutic targets in oncology.Highly sensitive detection of DNA methylation levels by using a quantum dot-based FRET method.FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
P2860
Q21558626-3FB6C2C8-F85B-4735-A734-AC32611D66B8Q26777395-CACDEE19-8E3A-4D14-89CC-E10EC7912B02Q26784448-1C7A5E36-503B-461D-859B-AC32F1BB980CQ26996421-761ADAA2-3D60-4879-9453-0CB6A8B758A7Q28085136-16BA3FB8-905C-4F83-89B8-73E11A9560B7Q30575636-88809E01-A300-4C6A-B33B-D85F764DBEC2Q33599244-5645AE4F-021F-42A5-89B5-23E0C65C3DFCQ33745551-B5E02201-749B-4BAE-91D5-5819B611796EQ33801377-7F175D2A-76C6-4CA5-A2F2-CCC9181F3A20Q34317992-067AF6D7-9955-4832-8B5A-B37377D26032Q34441327-050F0F35-17C0-46E7-B8AA-E1434F8197C4Q34902060-A2ABCCAC-8BA7-4EF1-979F-2CEE9122B47BQ35025525-54232A29-A7DE-4C71-A43F-E4D6B05D54A9Q35191841-794C5AED-CBAF-4F37-82EE-B1B8B1FB8C09Q35219683-ABE03B4E-5238-4867-8031-6D0E35F62B32Q35503066-BC649EA8-1C4B-401E-A8D4-8834EAFF24D4Q35572231-68DD163E-B193-48A1-9C05-A049E3950410Q35750355-902E2D08-BB57-45C7-93CF-138C6F747CD1Q35934694-88723044-5E44-46CD-90EB-A7DD718B0E8DQ36050701-5154C72A-D7A0-4770-A42E-60DE2D08BA3EQ36184277-20F2D378-98E3-4260-8495-BB8C3F8975FEQ36295062-F6D7C8B0-2744-47D4-879B-39C781F0E4D0Q36376817-668CE82F-9511-4699-AD5A-A76DF1025205Q36546750-A3B69E23-0DB4-455D-A34D-FD47AA8C182AQ36753730-B3D200EE-9C64-4359-A817-8482F6C821D7Q36812119-6CC1EEDF-11A9-43C1-993D-AE8C37BDADE1Q36848243-2CF90044-64DE-4DB1-AEEA-6DF1A427CA19Q36998647-218D8894-E405-4FC9-905F-89A72991C9D3Q37267725-8F5F3B8B-5132-4BBC-9DF6-48DA28E21DD1Q37290684-551AE0CE-901C-4AF9-B450-39222C320261Q37445217-4317E4B9-B09F-422C-A845-ABCD2C49C169Q37699587-E5755D89-C263-4345-B30C-A8CD21E9AB9AQ38097524-821124AE-8B57-4982-B1CD-22CD8EB116D0Q38123094-A5B74771-5529-4376-B8B5-D46FAA6A5C2EQ38216129-EEE1D9B2-FFEE-429D-9C72-C4D8652C7CFAQ38218848-F3711A92-99D3-405F-BC15-FDFDFE41AC00Q38296746-0F95FD04-2949-40FC-BA63-69ECA30CA113Q38591064-BAE08762-299F-4FB7-A375-B419AE269850Q38829611-B905B661-5546-4A76-822E-36E92667DEA1Q38949791-12242EB5-17B2-4E85-99FF-214D11FC53A4
P2860
DNA methylation biomarkers in cancer: progress towards clinical implementation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
DNA methylation biomarkers in cancer: progress towards clinical implementation.
@en
type
label
DNA methylation biomarkers in cancer: progress towards clinical implementation.
@en
altLabel
DNA methylation biomarkers in cancer: progress towards clinical implementation
@en
prefLabel
DNA methylation biomarkers in cancer: progress towards clinical implementation.
@en
P2860
P50
P356
P1476
DNA methylation biomarkers in cancer: progress towards clinical implementation.
@en
P2093
P2860
P304
P356
10.1586/ERM.12.45
P407
P577
2012-06-01T00:00:00Z